KIRO 7
Local dog survives cancer twice with experimental vaccine (opens in a new tab)
The written companion to the news segment above — how Rainier beat cancer twice and what his trial participation meant for other dogs.
May 1, 2025Read it
Rainier in the news
Sharing the story of a legacy.
Reporters and broadcasters have told Rainier's story — the Akita who lived with osteosarcoma and took part in an experimental immunotherapy vaccine. His journey helped carry the mission forward: more time, for more dogs.
KIRO 7: Rainier's story on local news
KIRO 7 featured Rainier's journey through osteosarcoma and the experimental vaccine trial that gave his family more time with him.
Video · 2:13 · Plays on this page
Publication details
3 pages · By Stephen Howie
Published May 5, 2025
Immunotherapy for dogs? Seattle-based nonprofit backs promising canine cancer vaccine
KUOW — Seattle's NPR news station — told Rainier's story in May 2025: the diagnosis that started it all, the trial at Washington State University's Veterinary Teaching Hospital, and the EGFR/HER2 vaccine that gave Rainier more time.
“We were told he had about two months to live and to give him the best life for a few months. I was devastated.”
3 pages · By Stephen Howie · Published May 5, 2025
Featured interview
In conversation about the vaccine.
Kasey joins the Canine Cancer Alliance alongside the families of Ranger and Codi — and Yale's Prof. Mark Mamula — to discuss how the EGFR/HER2 vaccine made metastases disappear in all three dogs.
Video interview · 1:13:07 · Starts at Kasey's story
Hosted by the Canine Cancer Alliance · April 2025 · Watch on YouTube
More coverage
More of Rainier in the press.
Reporters and partner organizations kept following Rainier's story through the vaccine trial.
MedPath
Yale's Experimental Cancer Vaccine Shows Remarkable Success in Canine Clinical Trials (opens in a new tab)
An industry look at the clinical trial, naming Rainier as one of the success stories alongside Lola, a golden retriever.
Apr 28, 2025Read it
Press contact
For media inquiries, interview requests, or coverage of The Rainier Legacy Project:
Want to support the mission? Learn more about us.